je.st
news
Arca Biopharma Upgraded to "Buy" by Zacks
2015-09-06 11:55:06| Biotech - Topix.net
The firm currently has a $1.25 target price on the biopharmaceutical company's stock. Zacks 's price target would suggest a potential downside of 80.47% from the stock's previous close.
Tags: buy
upgraded
arca
zacks
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||